A detailed history of Harbor Advisory Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Harbor Advisory Corp holds 28,571 shares of MRK stock, worth $3.31 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares
28,571
Previous 28,769 0.69%
Holding current value
$3.31 Million
Previous $3.8 Million 6.82%
% of portfolio
1.23%
Previous 1.3%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$123.8 - $132.96 $24,512 - $26,326
-198 Reduced 0.69%
28,571 $3.54 Million
Q1 2024

Apr 29, 2024

SELL
$113.24 - $131.95 $21,289 - $24,806
-188 Reduced 0.65%
28,769 $3.8 Million
Q4 2023

Feb 05, 2024

SELL
$100.18 - $109.02 $252,653 - $274,948
-2,522 Reduced 8.01%
28,957 $3.16 Million
Q3 2023

Oct 27, 2023

SELL
$102.95 - $114.33 $21,310 - $23,666
-207 Reduced 0.65%
31,479 $3.24 Million
Q2 2023

Aug 03, 2023

SELL
$108.61 - $118.38 $59,409 - $64,753
-547 Reduced 1.7%
31,686 $3.66 Million
Q1 2023

May 04, 2023

SELL
$102.94 - $114.86 $36,543 - $40,775
-355 Reduced 1.09%
32,233 $3.43 Million
Q4 2022

Feb 07, 2023

BUY
$87.44 - $112.11 $2.85 Million - $3.65 Million
32,588 New
32,588 $3.61 Million
Q3 2022

Oct 31, 2022

BUY
$84.53 - $94.96 $51,056 - $57,355
604 Added 1.89%
32,588 $2.81 Million
Q2 2022

Aug 01, 2022

BUY
$83.49 - $94.64 $35,566 - $40,316
426 Added 1.35%
31,984 $2.92 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $35,840 - $39,415
500 Added 1.61%
31,558 $2.37 Million
Q2 2021

Aug 04, 2021

BUY
$70.31 - $77.77 $1.43 Million - $1.58 Million
20,360 Added 190.32%
31,058 $2.42 Million
Q1 2021

May 13, 2021

BUY
$68.86 - $81.11 $205,271 - $241,788
2,981 Added 38.63%
10,698 $825,000
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $553,849 - $614,659
7,717 New
7,717 $631,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $293B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Harbor Advisory Corp Portfolio

Follow Harbor Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Advisory Corp , based on Form 13F filings with the SEC.

News

Stay updated on Harbor Advisory Corp with notifications on news.